鲁抗医药：关于控股子公司获得药品注册证书的公告

Core Viewpoint - The company has received a drug registration certificate for a new generic medication, indicating successful compliance with quality and efficacy standards [1] Group 1 - The company, Shandong Lukang Pharmaceutical Group Set Co., Ltd., a subsidiary of Lukang Pharmaceutical, has been granted a drug registration certificate by the National Medical Products Administration for sildenafil hydrochloride tablets [1] - The drug is classified as a generic medication under the new registration category 4, which signifies that it has passed the consistency evaluation of quality and efficacy for generic drugs [1]